{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:57:40Z","timestamp":1783108660127,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.01.106","type":"journal-article","created":{"date-parts":[[2007,2,16]],"date-time":"2007-02-16T12:21:47Z","timestamp":1171628507000},"page":"3871-3878","source":"Crossref","is-referenced-by-count":235,"title":["Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin"],"prefix":"10.1016","volume":"25","author":[{"given":"Rick A.","family":"Bright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Daniluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin R.","family":"Toapanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attiya","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gavrilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Massare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pushko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutan","family":"Mytle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gale","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2007.01.106_bib1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1086\/503405","article-title":"The economic impact of influenza in a university hospital setting","volume":"22","author":"Szucs","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2007.01.106_bib2","series-title":"Bascin and applied influenza research","first-page":"159","article-title":"The immune response to influenza viruses and the problem of protection against infection","author":"Askonas","year":"1982"},{"issue":"4","key":"10.1016\/j.vaccine.2007.01.106_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.00005-06","article-title":"Emerging respiratory viruses: challenges and vaccine strategies","volume":"19","author":"Gillim-Ross","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.106_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/JVI.24.1.170-176.1977","article-title":"Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells","volume":"24","author":"Schulman","year":"1977","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2007.01.106_bib5","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1016\/j.vaccine.2006.03.004","article-title":"Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection","volume":"24","author":"Mann","year":"2006","journal-title":"Vaccine"},{"issue":"9492","key":"10.1016\/j.vaccine.2007.01.106_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2007.01.106_bib7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005\u20132006 influenza season in the United States","volume":"295","author":"Bright","year":"2006","journal-title":"Jama"},{"issue":"50","key":"10.1016\/j.vaccine.2007.01.106_bib8","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2005.07.098","article-title":"Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB\/c mice","volume":"23","author":"Pushko","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.01.106_bib9","first-page":"193","article-title":"Application of an improved single-radial-immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunit influenza vaccines","volume":"39","author":"Wood","year":"1997","journal-title":"Dev Biol Stand"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.106_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0042-6822(03)00008-4","article-title":"Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine","volume":"308","author":"Bright","year":"2003","journal-title":"Virology"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2007.01.106_bib11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0264-410X(02)00539-X","article-title":"Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins","volume":"21","author":"Mitchell","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.106_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/77802","article-title":"C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge","volume":"1","author":"Ross","year":"2000","journal-title":"Nat Immunol"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2007.01.106_bib13","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.vaccine.2003.10.050","article-title":"Mouse strain-dependent differences in enhancement of immune responses by C3d","volume":"22","author":"Toapanta","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.01.106_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S0022172400022610","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.106_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00003495-200060010-00004","article-title":"Humoral immune response to influenza vaccination in patients from high risk groups","volume":"60","author":"Brydak","year":"2000","journal-title":"Drugs"},{"issue":"28","key":"10.1016\/j.vaccine.2007.01.106_bib16","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1016\/S0264-410X(00)00126-2","article-title":"Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases","volume":"18","author":"Brydak","year":"2000","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.01.106_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0753-3322(00)89025-3","article-title":"The epidemiology and history of influenza","volume":"54","author":"Kuszewski","year":"2000","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.106_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1742-1241.1997.tb09640.x","article-title":"Immunogenicity and tolerability of a trivalent influenza subunit vaccine (Influvac) in high-risk children aged 6 months to 4 years","volume":"51","author":"Daubeney","year":"1997","journal-title":"Br J Clin Pract"},{"issue":"3","key":"10.1016\/j.vaccine.2007.01.106_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0022172400064500","article-title":"A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection","volume":"92","author":"Masurel","year":"1984","journal-title":"J Hyg (Lond)"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.01.106_bib20","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1086\/514169","article-title":"Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs","volume":"176","author":"Palache","year":"1997","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2007.01.106_bib21","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/eji.1830241024","article-title":"Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines","volume":"24","author":"Kovacsovics-Bankowski","year":"1994","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.106_bib22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.virol.2006.08.032","article-title":"HIV-1 envelope on the surface of a lentiviral particle elicits broader immune responses than soluble envelopes","volume":"358","author":"McBurney","year":"2007","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.106_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/vim.2005.18.365","article-title":"Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge","volume":"18","author":"Galarza","year":"2005","journal-title":"Viral Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.106_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0042-6822(03)00372-6","article-title":"Enhancement of mucosal immune responses by chimeric influenza HA\/SHIV virus-like particles","volume":"313","author":"Guo","year":"2003","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.106_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/JVI.76.2.767-773.2002","article-title":"Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles","volume":"76","author":"Watanabe","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.106_bib26","first-page":"20","article-title":"Enhancement of mucosal immune responses by chimeric influenza HA\/SHIV virus-like particles","volume":"8","author":"Yao","year":"2003","journal-title":"Res Initiat Treat Action"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07001351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07001351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T18:32:27Z","timestamp":1683743547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07001351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":26,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07001351"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.01.106","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}